Claim Missing Document
Check
Articles

Found 3 Documents
Search

GC-MS Analysis Reveals Unique Chemical Composition of Blumea balsamifera (L.) DC in Ie-Jue Geothermal Area Nur Balqis Maulydia; Khairan Khairan; Trina Ekawati Tallei; Ethiene Castellucci Estevam; Mohsina Patwekar; Fazlin Mohd Fauzi; Rinaldi Idroes
Grimsa Journal of Science Engineering and Technology Vol. 1 No. 1 (2023): October 2023
Publisher : Graha Primera Saintifika

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61975/gjset.v1i1.6

Abstract

Blumea balsamifera (L.) DC. or Sembung is a flowering plant belonging to the genus Blumea of the family Asteraceae. Many pharmacological activities of this plant show potential in human therapy. In this study, an investigation was conducted on the ethanolic extract of B. balsamifera collected from a geothermal area known as Ie-Jue, in Aceh Province, Indonesia. The results showed that the ethanolic extract of B. balsamifera contained secondary metabolites of flavonoids and tannins. Chemical constituents of ethanolic extracts B. balsamifera further analysis using gas chromatography-mass spectrometry (GC-MS) show that active compounds from this plant was Proximadiol (C15H28O2) with relative area 41.76%. This research underscores the compelling potential of the Ie-Jue geothermal area as a promising reservoir of flora owing to the plant's adaptability to geothermal extremities.
Fine-Tuning ChemBERTa for Predicting Activity of AXL Kinase Inhibitors in Oncogenic Target Modeling Teuku Rizky Noviandy; Ghazi Mauer Idroes; Mohsina Patwekar; Rinaldi Idroes
Grimsa Journal of Science Engineering and Technology Vol. 3 No. 2 (2025): October 2025
Publisher : Graha Primera Saintifika

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61975/gjset.v3i2.98

Abstract

The development of selective kinase inhibitors remains a key objective in cancer drug discovery, where predictive computational models can significantly accelerate the identification of leads. In this study, we investigate the fine-tuning strategies of the transformer-based ChemBERTa model for quantitative structure–activity relationship (QSAR) modeling of AXL receptor tyrosine kinase inhibitors, an important therapeutic target implicated in tumor progression and metastasis. A dataset of AXL inhibitors was curated from the ChEMBL database. Three fine-tuning configurations, namely baseline, full fine-tune, and aggressive, were implemented to examine the influence of learning rate, weight decay, and the number of frozen transformer layers on model performance. Models were evaluated using accuracy, precision, recall, F1-score, and calibration metrics. Results showed that both the full fine-tune and aggressive configurations outperformed the baseline model, achieving higher precision and F1-scores while maintaining robust recall. The aggressive configuration achieved the most balanced performance, with improved calibration and the lowest expected calibration error, indicating reliable probabilistic predictions. Overall, this study highlights that controlled fine-tuning of ChemBERTa significantly enhances predictive performance and confidence estimation in QSAR modeling, offering valuable insights for optimizing transformer-based chemical language models in kinase-targeted drug discovery.
QSAR Modeling of Beta-2 Adrenergic Receptor Ligands Using Molecular Descriptor–Based Machine Learning Teuku Rizky Noviandy; Mohsina Patwekar; Rinaldi Idroes
Malacca Pharmaceutics Vol. 4 No. 1 (2026): March 2026
Publisher : Heca Sentra Analitika

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.60084/mp.v4i1.394

Abstract

The Beta-2 Adrenergic Receptor (ADRB2) is a well-characterized G protein–coupled receptor widely studied in pharmacology and drug discovery. In this study, quantitative structure–activity relationship (QSAR) models were developed using molecular descriptor–based machine learning approaches to predict the activity of ADRB2 ligands. A curated dataset of 745 compounds with experimentally determined IC₅₀ values was obtained from the ChEMBL database. Two-dimensional molecular descriptors were calculated and preprocessed to remove low-variance and highly correlated features, resulting in a refined feature set for model development. The dataset was categorized into active and inactive compounds and divided into training and testing subsets. Four machine learning algorithms. Logistic Regression, Support Vector Machine, Gradient Boosting, and Random Forest were implemented and evaluated using accuracy, precision, recall, F1-score, and ROC-AUC metrics. Among the models, Random Forest achieved the best performance, with an accuracy of 89.26%, F1-score of 89.87%, and AUC of 0.926, followed by Gradient Boosting with an accuracy of 87.92% and AUC of 0.922. Analysis of physicochemical descriptors indicated that hydrogen-bond donor capacity (nHD) shows a statistically significant association with variations in compound activity toward ADRB2, while lipophilicity (LogP) and hydrogen-bond acceptor count (nHA) do not exhibit statistically significant differences between activity classes. Overall, the results demonstrate that molecular descriptor–based machine learning models, particularly ensemble methods, provide an effective framework for predicting ADRB2-related compound activity and support the prioritization of candidate molecules in computational drug discovery.